Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

331 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A multimarker prognostic assay for primary cutaneous melanoma.
Kashani-Sabet M, Venna S, Nosrati M, Rangel J, Sucker A, Egberts F, Baehner FL, Simko J, Leong SP, Haqq C, Hauschild A, Schadendorf D, Miller JR 3rd, Sagebiel RW. Kashani-Sabet M, et al. Among authors: simko j. Clin Cancer Res. 2009 Nov 15;15(22):6987-92. doi: 10.1158/1078-0432.CCR-09-1777. Epub 2009 Nov 3. Clin Cancer Res. 2009. PMID: 19887476 Free PMC article.
Whole genome scanning identifies genotypes associated with recurrence and metastasis in prostate tumors.
Paris PL, Andaya A, Fridlyand J, Jain AN, Weinberg V, Kowbel D, Brebner JH, Simko J, Watson JE, Volik S, Albertson DG, Pinkel D, Alers JC, van der Kwast TH, Vissers KJ, Schroder FH, Wildhagen MF, Febbo PG, Chinnaiyan AM, Pienta KJ, Carroll PR, Rubin MA, Collins C, van Dekken H. Paris PL, et al. Among authors: simko j. Hum Mol Genet. 2004 Jul 1;13(13):1303-13. doi: 10.1093/hmg/ddh155. Epub 2004 May 11. Hum Mol Genet. 2004. PMID: 15138198
Bladder cancer outcome and subtype classification by gene expression.
Blaveri E, Simko JP, Korkola JE, Brewer JL, Baehner F, Mehta K, Devries S, Koppie T, Pejavar S, Carroll P, Waldman FM. Blaveri E, et al. Clin Cancer Res. 2005 Jun 1;11(11):4044-55. doi: 10.1158/1078-0432.CCR-04-2409. Clin Cancer Res. 2005. PMID: 15930339
Ribozyme-mediated targeting of IkappaBgamma inhibits melanoma invasion and metastasis.
Torabian SZ, de Semir D, Nosrati M, Bagheri S, Dar AA, Fong S, Liu Y, Federman S, Simko J, Haqq C, Debs RJ, Kashani-Sabet M. Torabian SZ, et al. Among authors: simko j. Am J Pathol. 2009 Mar;174(3):1009-16. doi: 10.2353/ajpath.2009.080207. Epub 2009 Jan 29. Am J Pathol. 2009. PMID: 19179607 Free PMC article.
A multi-marker assay to distinguish malignant melanomas from benign nevi.
Kashani-Sabet M, Rangel J, Torabian S, Nosrati M, Simko J, Jablons DM, Moore DH, Haqq C, Miller JR 3rd, Sagebiel RW. Kashani-Sabet M, et al. Among authors: simko j. Proc Natl Acad Sci U S A. 2009 Apr 14;106(15):6268-72. doi: 10.1073/pnas.0901185106. Epub 2009 Mar 30. Proc Natl Acad Sci U S A. 2009. PMID: 19332774 Free PMC article.
Preliminary evaluation of prostate cancer metastatic risk biomarkers.
Paris PL, Weinberg V, Simko J, Andaya A, Albo G, Rubin MA, Carroll PR, Collins C. Paris PL, et al. Among authors: simko j. Int J Biol Markers. 2005 Jul-Sep;20(3):141-5. doi: 10.1177/172460080502000301. Int J Biol Markers. 2005. PMID: 16247872 Free article.
331 results